课题基金 / 基金详情

项目摘要

项目成果

Bruce Edward Torbett的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The major goal of this application is to purchase a Gammacell 40 Exactor, a gamma irradiator, for use in irradiation of mice, cells, and tissue. The major users of the instrument are NIH funded investigators whose work is heavily dependent on the use of a gamma irradiator device. Major users projects included in this application cover a variety of disciplines, including: endothelial progenitor function and angiogenesis in mice and humanized mice; hematopoietic stem cell transplantation, differentiation, and leukemia development in mice; mouse models for investigating the regulation of iron homeostasis; oxidant stress in hematopoietic cell development in mice; humanized mouse models for hematopoietic stem cell anti-HIV-1 gene delivery and HIV-1 pathogenic studies; mouse models for cell transplantation and islet xenotransplantation; autoimmune disease models; breast cancer metastasis; preclinical studies using mouse models to evaluate the ability of activated protein C to reduce mortality caused by radiation DNA damage induced cell cycle check point control; and small interference RNA and ribozymes in treating HIV infection. We are requesting a state-of-the-art gamma irradiator that will allow us to continue currently funded studies and will accommodate anticipated increased demand for irradiator access that cannot be met by our current 27 year old Model 143-35 gamma irradiator due to limitations of capacity and degrading mechanical function due to advanced age. Objective: The long-term objective of this proposal is to provide researchers at The Department of Molecular and Experimental Medicine and The Scripps Research Institute a current generation gamma irradiator that provides humane, reliable, reproducible, and trouble free irradiation for the treatment of small animals. This instrument will also be used for treatment of cells and tissues. Relevance: Identified user groups are all involved in disease specific research that is highly relevant to human health, and receive support from several NIH institutes. The investigations span the research spectrum from insight into basic cellular and molecular mechanism to preclinical models.7. Project narrative:
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Admin Core
  • 批准号:
    10508444
  • 项目类别:
  • 资助金额:
    $32.17万
  • 财政年份:
    2022
  • 负责人:
    Bruce Edward Torbett
  • 依托单位:
Dynamics of HIV Packaging and Assembly
  • 批准号:
    10650888
  • 项目类别:
  • 资助金额:
    $56.79万
  • 财政年份:
    2022
  • 负责人:
    Bruce Edward Torbett
  • 依托单位:
Dynamics of HIV Packaging and Assembly
  • 批准号:
    10508452
  • 项目类别:
  • 资助金额:
    $74.66万
  • 财政年份:
    2022
  • 负责人:
    Bruce Edward Torbett
  • 依托单位:
Admin Core
  • 批准号:
    10650866
  • 项目类别:
  • 资助金额:
    $31.96万
  • 财政年份:
    2022
  • 负责人:
    Bruce Edward Torbett
  • 依托单位:
国内基金
海外基金
Handbook of the Mathematics of the Arts and Sciences的中文翻译
  • 批准号:
    12226504
  • 项目类别:
    数学天元基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2022
  • 负责人:
    黄朝凌
  • 依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    35万元
  • 批准年份:
    2020
  • 负责人:
    陈加祥
  • 依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
  • 批准号:
    82060278
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2020
  • 负责人:
    陈加祥
  • 依托单位:
促进肿瘤凋亡的融合蛋白CPP-TRAIL-ARTS C27的制备及机制研究
  • 批准号:
    81372444
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2013
  • 负责人:
    易成
  • 依托单位: